BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2359082)

  • 1. Eosinophilic fasciitis after allogeneic bone marrow transplantation.
    Markusse HM; Dijkmans BA; Fibbe WE
    J Rheumatol; 1990 May; 17(5):692-4. PubMed ID: 2359082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic fasciitis after allogeneic stem cell transplantation: a case report and review of the literature.
    Ustun C; Ho G
    Leuk Lymphoma; 2004 Aug; 45(8):1707-9. PubMed ID: 15370231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.
    Schaffer JV; McNiff JM; Seropian S; Cooper DL; Bolognia JL
    J Am Acad Dermatol; 2005 Oct; 53(4):591-601. PubMed ID: 16198778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse fasciitis after bone marrow transplantation.
    van den Bergh V; Tricot G; Fonteyn G; Dom R; Bulcke J
    Am J Med; 1987 Jul; 83(1):139-43. PubMed ID: 3300320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature.
    Ota M; Shimizu T; Hashino S; Shimizu H
    Am J Hematol; 2004 Jul; 76(3):295-6. PubMed ID: 15224372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe Shulman's syndrome by allogeneic bone marrow transplantation.
    Cetkovský P; Koza V; Cetkovská P; Svojgrová M
    Bone Marrow Transplant; 1998 Mar; 21(6):637-9. PubMed ID: 9543071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME; Bolwell BJ
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic folliculitis: an important differential diagnosis after allogeneic bone-marrow transplant.
    Fraser SJ; Benton EC; Roddie PH; Krajewski AS; Goodlad JR
    Clin Exp Dermatol; 2009 Apr; 34(3):369-71. PubMed ID: 19040519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypereosinophilia after allogeneic bone marrow transplantation. A possible role of IL-5 overproduction by donor T-cells chronic GVHD].
    Masumoto A; Sasao T; Yoshiba F; Kato S; Mori A; Okudaira H; Hotta T
    Rinsho Ketsueki; 1997 Mar; 38(3):234-6. PubMed ID: 9095665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
    Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
    Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
    Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic fasciitis following allogeneic bone marrow transplantation in a patient with acute myeloid leukaemia.
    Chu GY; Lin HL; Chen GS; Wu CY
    Acta Derm Venereol; 2014 Mar; 94(2):221-2. PubMed ID: 24002569
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT.
    Oda K; Nakaseko C; Ozawa S; Nishimura M; Saito Y; Yoshiba F; Yamashita T; Fujita H; Takasaki H; Kanamori H; Maruta A; Sakamaki H; Okamoto S;
    Bone Marrow Transplant; 2009 Jan; 43(2):159-67. PubMed ID: 18762758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.